SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

DaVita Inc

DaVita ($DVA) is trending due to community interest in its potential adoption of DefenCath, a product aimed at reducing infections in dialysis patients, with some suggesting DaVita's mortality rates could improve with its use.  There is discussion around recent data showing USRC improved with only ~6 months of DefenCath, DaVita improved operationally, Fresenius flat.  Additionally, some analysts point out Berkshire Hathaway's large stake in DaVita and the recent double bottom.

$4CHAN is a meme token on the Ethereum Network.   4ChanToken represents a global crypto community that pays homage to the memetic powerhouses of the internet as Pepe, Doge, Shib and all major memes inventor combining them all into one super meme token that is $4CHAN. At its core, 4ChanToken embodies the untamed spirit of the notorious 4chan imageboard, where iconic memes are born, nurtured, and unleashed upon the world. With an unyielding spirit of irreverence and a touch of mischief, $4CHAN has emerged as the darling of meme enthusiasts, internet dwellers, and crypto aficionados alike.   The foundation of 4ChanToken lies in its community. We’ve harnessed the chaotic energy of this digital realm to create a currency that celebrates the power of memetic expression, empowering users to engage in a truly unique and decentralized economy. As a passionate supporter, you’ll join a vibrant ecosystem where dank memes and viral sensations are the lifeblood of commerce. 4ChanToken is more than just a digital currency – it’s the place where memes are born.  The ultimate playground for memelords and crypto degens. Based on the simplicity of holdrs/volume operating a store of value.  The identification of this value is best described as 'digital gold'. That $4chan can ultimately represent a superior store of value relative to all other forms of memecoins by embodying all memes in one token as the factual birthplace of all popular memes.

4Chan

4Chan Crypto is trending as the community rallies around its memetic origins and potential for significant gains, touting its unique position as the '$BTC of memecoins' with 13 zeros. Discussions revolve around the strength of its decentralized nature, community-led initiatives, and resilience during market downturns, with holders encouraging others to 'swap' and accumulate while prices are discounted. Some users suggest that the coin's origins mean there's potential for fast growth.

ICU Medical, Inc. engages in the provision of innovative medical products used in infusion therapy and critical care applications. Its product portfolio includes IV smart pumps, sets, connectors, closed system transfer devices for hazardous drugs, sterile IV solutions, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA.

ICU Medical, Inc.

ICU Medical is trending as the Street digests updated ratings and price targets following recent financial updates. Community chatter highlights both positive analyst outlooks and concerns regarding company management and risk factors such as tariffs. Discussions also focus on potential upside from market share gains, strategic joint ventures, and the integration of past acquisitions.

Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Fresenius Medical Care AG - ADR

Fresenius Medical Care AG & Co. KGAA

FMS is trending as investors digest the potential impact of real-world evidence concerning DefenCath and its adoption within Fresenius facilities. Discussions center on the reduction of bloodstream infections and hospitalizations in dialysis patients, particularly compared to competitors. The community is also closely monitoring Wall Street's EPS expectations for the upcoming Q4 report.

Barrick Mining Corp. engages in the production and sale of gold, copper, and related activities. It also provides exploration and mining development. It operates through the following business segments: Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, Bulyanhulu, and Other Mines. The company was founded by Peter D. Munk in 1983 and is headquartered in Toronto, Canada.

Barrick Mining Corp.

Barrick Mining Corp

Barrick Mining is trending as gold prices reach record highs, sparking discussions about the company's potential for further growth and profitability, though some analysts note rising costs could be a headwind. Community members are actively discussing potential acquisitions, divestitures, and the impact of global economic factors on the mining sector. Additionally, there is some concern about Barrick's stock underperforming compared to the metal itself.

Themes ETF Trust - Leverage Shares 2X Long BBAI Daily ETF

Leverage Shares 2X Long BBAI Daily ETF

The Leverage Shares 2X Long BBAI Daily ETF ($BAIG) is trending as traders seek amplified exposure to $BBAI, with many discussing strategies around swing trading and long-term holds. Community members are sharing their bullish positions and discussing entry and exit points, while also weighing the risks associated with leveraged ETFs. Mentions of mentorship programs and potential news catalysts are further fueling the conversation.

Fidelity Wise Origin Bitcoin Fund - Fidelity Wise Origin Bitcoin Fund Beneficial Interest

Fidelity Wise Origin Bitcoin Fund

FBTC is gaining traction as Bitcoin ETFs experience significant inflows, reflecting investor confidence amid market volatility. Community members are dollar-cost averaging into FBTC, while analysts suggest Bitcoin is undervalued compared to gold. Discussions also involve potential impacts from macroeconomic factors and regulatory developments.

Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment consists of end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through the company's two core offerings, Canopy and Horizon. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

Ginkgo Bioworks is trending as discussions highlight the potential for government funding and biosecurity initiatives to drive growth, with the community viewing it as more than a contract R&D service and highlighting platform leverage. Some investors are pointing towards the importance of securing government contracts and growth in new segments of the business, while others are more skeptical, pointing towards continued year-over-year revenue declines. Additionally, some see a potential link between Ginkgo and Cronos' work in pharmaceutical-grade cannabinoids.

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

SCHD is trending as investors debate its merits as a defensive ETF in the current market conditions, with some expressing frustration over its recent underperformance compared to growth-focused investments. Discussions revolve around the ETF's dividend yield, sector allocation, and potential for future growth amid changing economic landscapes. Community members are weighing SCHD's value as a long-term income generator against the opportunity costs of potentially higher returns elsewhere.

KraneShares Trust - KraneShares CSI China Internet ETF

KraneShares CSI China Internet ETF

KWEB is trending amid optimism surrounding potential trade de-escalation between the U.S. and China, with many traders pointing to technical indicators suggesting a breakout. Community members are actively discussing China's economic policies and their potential impact on internet companies within the ETF. Bullish sentiment seems to be growing as investors speculate on increased capital flowing into Chinese equities.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Buy These 5 Best Value Stocks to Make the Most of P/B Ratio

Discover five low P/B picks like STNE that are undervalued and show solid growth potential based on value-focused filters.

KROS or NVZMY: Which Is the Better Value Stock Right Now?

KROS vs. NVZMY: Which Stock Is the Better Value Option?

How Much Upside is Left in Keros Therapeutics (KROS)? Wall Street Analysts Think 34.24%

The consensus price target hints at a 34.2% upside potential for Keros Therapeutics (KROS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Keros Therapeutics (NASDAQ:KROS) Shares Gap Down - Here's Why

Keros Therapeutics (NASDAQ:KROS) Shares Gap Down - Time to Sell...

Los Angeles Capital Management LLC Purchases New Stake in Keros Therapeutics, Inc. $KROS

Los Angeles Capital Management LLC acquired a new position in Keros Therapeutics, Inc. (NASDAQ:KROS - Free Report) in the 2nd quarter, according to the company in its most recent filing with the...

Connor Clark & Lunn Investment Management Ltd. Boosts Stake in Keros Therapeutics, Inc. $KROS

Connor Clark & Lunn Investment Management Ltd. raised its holdings in Keros Therapeutics, Inc. (NASDAQ:KROS - Free Report) by 107.4% during the 2nd quarter, according to the company in its most...

Keros Therapeutics' (KROS) Outperform Rating Reiterated at Oppenheimer

Oppenheimer restated an "outperform" rating and issued a $27.00 target price (up previously from $23.00) on shares of Keros Therapeutics in a research report on Wednesday...

5 Undervalued Stocks That Are Poised for Growth in November

Five undervalued picks -  including StoneCo and MillerKnoll - shine with strong growth prospects and low price-to-book ratios this November.

Wells Fargo & Company Lowers Keros Therapeutics (NASDAQ:KROS) Price Target to $23.00

Wells Fargo & Company reduced their target price on Keros Therapeutics from $26.00 to $23.00 and set an "overweight" rating on the stock in a research report on Tuesday...

KROS vs. ARGX: Which Stock Is the Better Value Option?

Keros Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with unmet medical need. The company was founded in 2015 and is headquartered in Lexington, MA.

Keros Therapeutics Inc

$AMZN

$MSFT

$GOOGL

$ORCL

Which cloud infrastructure stock offers the best long-term opportunity right now?

Current Price	$17.48
Prev Close	$17.50
Open	$17.71
Dividend Yield	0.00%
50-Day Moving Average	$15.94
Beta	0.88
Avg. Volume	1.06M
PE Ratio	11.33

52-Week High	$72.37
52-Week Low	$9.12
Market Capitalization	$532.55M
EPS (Annual)	-$5.00
Price to Book	1.01
Revenue Per Employee	$21,005.92
Enterprise Value/EBITDA	N/A

KROS
Keros Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest KROS News

KROSKeros Therapeutics Inc